请翻译：Form 10QSB for MELO BIOTECHNOLOGY HOLDINGS INC.


--------------------------------------------------------------------------------

20-Aug-2007

Quarterly Report



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Special Cautionary Note Regarding Forward Looking Statements

Certain statements in this quarterly report, including statements in the following discussion, which are not statements of historical fact, are what are known as "forward-looking statements," which are basically statements about the future. For that reason, these statements involve risk and uncertainty since no one can accurately predict the future. Words such as "plans," "intends," "will," "hopes," "seeks," "anticipates," "expects," and the like, often identify such forward-looking statements, but are not the only indication that a statement is a forward-looking statement. Such forward-looking statements include statements concerning our plans and objectives with respect to the present and future operations of the Company, and statements which express or imply that such present and future operations will or may produce revenues, income or profits. Numerous factors and future events could cause the Company to change such plans and objectives, or fail to successfully implement such plans or achieve such objectives, or cause such present and future operations to fail to produce revenues, income or profits. Therefore, the reader is advised that the following discussion should be considered in light of the discussion of risks and other factors contained in this report on Form 10-QSB and in the Company's other filings with the Securities and Exchange Commission. No statements contained in the following discussion should be construed as a guarantee or assurance of future performance or future results.

Overview

Melo Biotechnology Holdings Inc., ("We," the "Company," or "Melo") a Canadian corporation formerly known as MIAD Systems Ltd. was formed in March 1993. The Company was initially established as a full-line supplier of business computer systems, as well as a provider of computer warranty, maintenance, installation and networking services. On October 1, 2006, the Company formed a wholly-owned subsidiary, Melo Biotechnology Limited ("Melo Limited"), a British Virgin Islands corporation, to engage in the sales of health products throughout Hong Kong and China (the "Territory"). Through Melo Limited, the Company engages in the sale of dietary nutritional supplements in the Territory.

Following the commencement of the business operations of Melo Limited, the Company entered into an Asset Sale, Purchase and Transfer Agreement with MIAD Information Systems Ltd. (the "Buyer"), a Canadian corporation, for the purchase and sale of all of the rights, properties, and assets used in the conduct of the Company's Computer Distribution Business. Under the Asset Sale, Purchase and Transfer Agreement, the Company sold to the Buyer all of the righ

形式10qsb为甜瓜生物科技控股公司


-------------------------------------------------- ----------------------

20 -8月- 2 007年

季度报告



项目2 。管理层的讨论与分析或行动计划
特别提醒大家注意关于前瞻性声明

某些陈述，在这个季度报告中的陈述，包括在随后的讨论中，不属于历史事实的陈述，是所谓的"前瞻性声明" ，这是一种基本的声明对未来充满信心。出于这个原因，这些陈述涉及到风险和不确定性，因为没有人能准确地预测未来。词语，如"计划" ， "打算" ， "将要" ， "希望" ， "寻求" ， "预期" ， "期望" ，等等，往往找出这些前瞻性声明，但不是唯一的迹象声明是一个具有前瞻性的发言。这些前瞻性陈述包括关于我们的计划和目标，针对当前和未来的作战中，该公司和报表，其中明示或暗示这种目前和未来的业务将或可能产生的收入，收入或利润。诸多因素及未来发生的事件可能会导致该公司为了改变这种计划和目标，或未能成功地实施这样的计划或达到这样的目标，或导致当前和未来的作战中，以不产生收入，收入或利润。因此，请读者表示，经讨论后，应考虑根据讨论的风险和其他因素，包含在这份报告中的表10 - qsb并在该公司的另一家提交给美国证券交易委员会的文件。没有报表所载在随后的讨论中应被视为担保或保证今后的业绩或未来的结果。

概况

甜瓜生物科技集团股份有限公司（简称"我们" ， "公司"或"甜瓜" ）的加拿大公司，以前称为miad系统有限公司成立于1993年3月。该公司最初成立的一个全系列供应商的商业计算机系统，以及提供电脑保修，维修，安装和网络服务。于2006年10月1日，该公司成立了一家全资附属公司，甜瓜生物技术有限公司（简称"甜瓜有限公司" ） ，英属维尔京群岛的公司，从事销售的健康产品在整个香港和中国（ "领土" ） 。通过甜瓜有限的情况下，公司主要从事买卖的膳食营养补充剂在该领土。

之后展开的业务运作，香瓜有限公司，该公司签订了一项资产出售，购买及转让协议与miad信息系统有限公司（ "买方" ） ，一家加拿大公司，用于购买和出售的一切权利，性能和资产使用的行为，该公司的电脑分销业务。根据资产出售，购买和转让协议，本公司出售给买方，所有的正确